2024

1. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

   European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

   Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

3. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024

   Journal of Heart and Lung Transplantation, Vol. 43, Núm. 10, pp. 1529-1628.e54

4. The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary

   Future Cardiology, Vol. 20, Núm. 11-12, pp. 595-603